Aigen Investment Management, LP Mersana Therapeutics, Inc. Transaction History

Aigen Investment Management, LP

  • $487 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
BUY
$2.0 - $4.45 $51,106 - $113,710
25,553 Added 104.17%
50,083 $100,000
Q1 2024

May 14, 2024
BUY
$2.16 - $5.94 $52,984 - $145,708
24,530 New
24,530 $109,000
Q3 2020

Nov 06, 2020
SELL
$16.2 - $25.7 $233,344 - $370,182
-14,404 Closed
0 $0
Q2 2020

Aug 10, 2020
BUY
$5.24 - $23.4 $75,476 - $337,053
14,404 New
14,404 $337,000

Others Institutions Holding MRSN

# of Institutions
121
Shares Held
116M
Call Options Held
233K
Put Options Held
457K
View Full List

About Mersana Therapeutics, Inc.

MRSN Quotes by TradingView
  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $215M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Aigen Investment Management, LP Portfolio

Follow Aigen Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Aigen Investment Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email